Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats : therapeutic implications for traumatic stress exposure
RATIONALE: Evaluation of pharmacotherapies for acute stress disorder (ASD) or post-traumatic stress disorder (PTSD) is challenging due to robust heterogeneity of trauma histories and limited efficacy of any single candidate to reduce all stress-induced effects. Pursuing novel mechanisms, such as the nociceptin/orphanin FQ (NOP) system, may be a viable path for therapeutic development and of interest as it is involved in regulation of relevant behaviors and recently implicated in PTSD and ASD.
OBJECTIVES: First, we evaluated NOP receptor antagonism on general behavioral performance and again following a three-species predator exposure model (Experiment 1). Then, we evaluated effects of NOP antagonism on fear memory expression (Experiment 2).
METHODS: Adult, male rats underwent daily administration of NOP antagonists (J-113397 or SB-612,111; 0-20 mg/kg, i.p.) and testing in acoustic startle, elevated plus maze, tail-flick, and open field tests. Effects of acute NOP antagonism on behavioral performance following predator exposure were then assessed. Separately, rats underwent fear conditioning and were later administered SB-612,111 (0-3 mg/kg, i.p.) prior to fear memory expression tests.
RESULTS: J-113397 and SB-612,111 did not significantly alter most general behavioral performance measures alone, suggesting minimal off-target behavioral effects of NOP antagonism. J-113397 and SB-612,111 restored performance in measures of exploratory behavior (basic movements on the elevated plus maze and total distance in the open field) following predator exposure. Additionally, SB-612,111 significantly reduced freezing behavior relative to control groups across repeated fear memory expression tests, suggesting NOP antagonism may be useful in dampening fear responses. Other measures of general behavioral performance were not significantly altered following predator exposure.
CONCLUSIONS: NOP antagonists may be useful as pharmacotherapeutics for dampening fear responses to trauma reminders, and the present results provide supporting evidence for the implication of the NOP system in the neuropathophysiology of dysregulations in fear learning and memory processes observed in trauma- and stress-related disorders.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:237 |
|---|---|
| Enthalten in: |
Psychopharmacology - 237(2020), 10 vom: 01. Okt., Seite 2943-2958 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Taylor, Rachel M [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.01.2021 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00213-020-05582-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311663575 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311663575 | ||
| 003 | DE-627 | ||
| 005 | 20231227130301.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00213-020-05582-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1224.xml |
| 035 | |a (DE-627)NLM311663575 | ||
| 035 | |a (NLM)32588078 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Taylor, Rachel M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats |b therapeutic implications for traumatic stress exposure |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2021 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a RATIONALE: Evaluation of pharmacotherapies for acute stress disorder (ASD) or post-traumatic stress disorder (PTSD) is challenging due to robust heterogeneity of trauma histories and limited efficacy of any single candidate to reduce all stress-induced effects. Pursuing novel mechanisms, such as the nociceptin/orphanin FQ (NOP) system, may be a viable path for therapeutic development and of interest as it is involved in regulation of relevant behaviors and recently implicated in PTSD and ASD | ||
| 520 | |a OBJECTIVES: First, we evaluated NOP receptor antagonism on general behavioral performance and again following a three-species predator exposure model (Experiment 1). Then, we evaluated effects of NOP antagonism on fear memory expression (Experiment 2) | ||
| 520 | |a METHODS: Adult, male rats underwent daily administration of NOP antagonists (J-113397 or SB-612,111; 0-20 mg/kg, i.p.) and testing in acoustic startle, elevated plus maze, tail-flick, and open field tests. Effects of acute NOP antagonism on behavioral performance following predator exposure were then assessed. Separately, rats underwent fear conditioning and were later administered SB-612,111 (0-3 mg/kg, i.p.) prior to fear memory expression tests | ||
| 520 | |a RESULTS: J-113397 and SB-612,111 did not significantly alter most general behavioral performance measures alone, suggesting minimal off-target behavioral effects of NOP antagonism. J-113397 and SB-612,111 restored performance in measures of exploratory behavior (basic movements on the elevated plus maze and total distance in the open field) following predator exposure. Additionally, SB-612,111 significantly reduced freezing behavior relative to control groups across repeated fear memory expression tests, suggesting NOP antagonism may be useful in dampening fear responses. Other measures of general behavioral performance were not significantly altered following predator exposure | ||
| 520 | |a CONCLUSIONS: NOP antagonists may be useful as pharmacotherapeutics for dampening fear responses to trauma reminders, and the present results provide supporting evidence for the implication of the NOP system in the neuropathophysiology of dysregulations in fear learning and memory processes observed in trauma- and stress-related disorders | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ASD | |
| 650 | 4 | |a Acoustic startle | |
| 650 | 4 | |a Anxiety | |
| 650 | 4 | |a Elevated plus maze | |
| 650 | 4 | |a Fear learning and memory | |
| 650 | 4 | |a Nociceptin/orphanin receptor | |
| 650 | 4 | |a Open field | |
| 650 | 4 | |a PTSD | |
| 650 | 4 | |a Rat | |
| 650 | 4 | |a Tail-flick | |
| 650 | 7 | |a Benzimidazoles |2 NLM | |
| 650 | 7 | |a Cycloheptanes |2 NLM | |
| 650 | 7 | |a J 113397 |2 NLM | |
| 650 | 7 | |a Opioid Peptides |2 NLM | |
| 650 | 7 | |a Piperidines |2 NLM | |
| 650 | 7 | |a Receptors, Opioid |2 NLM | |
| 650 | 7 | |a cis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |2 NLM | |
| 650 | 7 | |a Nociceptin Receptor |2 NLM | |
| 650 | 7 | |a Oprl protein, rat |2 NLM | |
| 700 | 1 | |a Jeong, Isaac H |e verfasserin |4 aut | |
| 700 | 1 | |a May, Matthew D |e verfasserin |4 aut | |
| 700 | 1 | |a Bergman, Elizabeth M |e verfasserin |4 aut | |
| 700 | 1 | |a Capaldi, Vincent F |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Nicole L T |e verfasserin |4 aut | |
| 700 | 1 | |a Matson, Liana M |e verfasserin |4 aut | |
| 700 | 1 | |a Lowery-Gionta, Emily G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Psychopharmacology |d 1977 |g 237(2020), 10 vom: 01. Okt., Seite 2943-2958 |w (DE-627)NLM00009434X |x 1432-2072 |7 nnns |
| 773 | 1 | 8 | |g volume:237 |g year:2020 |g number:10 |g day:01 |g month:10 |g pages:2943-2958 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00213-020-05582-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 237 |j 2020 |e 10 |b 01 |c 10 |h 2943-2958 | ||